Glycophos
Product Images NDC 63323-241

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycophos (NDC 63323-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Comparison

Comparison
A table comparing various potassium and sodium phosphate injection vials alongside Glycophos sterile concentrate. It displays images of the vials, their NDC numbers, fill volumes, and manufacturers. Potassium phosphate injections by Pfizer and Fresenius Kabi USA range from 5 to 50 mL. Sodium phosphate injections from Pfizer, Fresenius Kabi USA, and American Regent range from 5 to 50 mL. Glycophos sterile concentrate by Fresenius Kabi USA is shown as a 20 mL vial with organic phosphate content.*
FDA Label Image

Vial-lyv1963 (Glycophos Figure 1 Vial Lv1963)

Vial-lyv1963 (Glycophos Figure 1 Vial Lv1963)
Label panel for Glycophos sterile concentrate by Fresenius Kabi USA, LLC. It indicates that 1 ml contains 1.0 mmol phosphate and 2.0 mmol sodium, with a warning that it must not be injected undiluted. The label also includes a section for the use-by date.*
FDA Label Image

Carton-lyv1963 (Glycophos Figure 2 Carton Lyv1963)

Carton-lyv1963 (Glycophos Figure 2 Carton Lyv1963)
The Glycophos sterile concentrate carton label shows a package containing 10 vials of 20 ml each. The label includes the Glycophos brand name and states it is manufactured by Fresenius Kabi USA, LLC. It lists sodium glycerophosphate pentahydrate as the active ingredient, along with storage warnings and manufacturing details from Fresenius Kabi Norge AS, Norway, for Fresenius Kabi AB, Sweden.*
FDA Label Image

Market

Market
Text describing Glycophos, an organic phosphate injection with 1 mMol phosphate per mL, emphasizing its non-preservative, single-use status, need for dilution before administration, contraindications, aluminum content, and precautions about barcode use and container materials. It also references a product comparison table for phosphate injection products in the U.S.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.